Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

S Galmiche, LBL Nguyen, E Tartour… - Clinical Microbiology …, 2022 - Elsevier
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

COVID-19 and liver disease

JF Dufour, T Marjot, C Becchetti, H Tilg - Gut, 2022 - gut.bmj.com
Knowledge on SARS-CoV-2 infection and its resultant COVID-19 in liver diseases has
rapidly increased during the pandemic. Hereby, we review COVID-19 liver manifestations …

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

P Toniutto, E Falleti, S Cmet, A Cussigh, L Veneto… - Journal of …, 2022 - Elsevier
Background & Aims The long-term immunogenicity of anti-SARS-CoV-2 vaccines in liver
transplant (LT) recipients is unknown. We aimed to assess the long-term antibody response …

Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis

HS Meshram, V Kute, H Rane, R Dave… - Transplant Infectious …, 2022 - Wiley Online Library
Background We aimed to analyze the humoral and cellular response to standard and
booster (additional doses) COVID‐19 vaccination in solid organ transplantation (SOT) and …

Humoral response to 2-dose BNT162b2 mRNA COVID-19 vaccination in liver transplant recipients

M Guarino, I Esposito, G Portella, V Cossiga… - Clinical …, 2022 - Elsevier
Background & Aims In the context of the Italian severe acute respiratory syndrome
coronavirus 2 vaccination program, liver transplant (LT) recipients were prioritized for …